clinical trials reviewed here show octreotide useful in the treatment of diarrhea associated with vip secreting tumors , as well as diarrhea and flushing associated with carcinoid syndrome , both conditions for which the drug is approved .
C0028833
octreotide
C0011991
diarrhea